Low Strength IDP-108
DrugTopical application once a day for 9 months
NCT Number: NCT00777868
The purpose of this study is to assess the safety and effectiveness of two concentrations of IDP-108 in treating patients with onychomycosis
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 2
Unidad de Investigación en Salud, Chihuahua City, Chihuahua, Mexico
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Topical application once a day for 9 months
Topical application once a day for 9 months
Topical application once a day for 9 months
Topical application once a day for 9 months
Time frame: 9 months
Time frame: 9 months
Dow Pharmaceutical Sciences
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06175013
Bacterial Infections and Mycoses, Dermatomycoses
Quatres Bornes, Mauritius
View Trial DetailsNCT05202366
Bacterial Infections and Mycoses, Dermatomycoses
Fort Worth, Texas, United States
View Trial DetailsNCT00233493
Bacterial Infections and Mycoses, Dermatomycoses
Cleveland, Ohio, United States
View Trial DetailsNCT05626270
Bacterial Infections and Mycoses, Dermatomycoses
Melbourne, Florida, United States
View Trial Details